My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Oklo Stock Slides As Short Seller Sets Sights...
Netflix Faces Class-Action Lawsuit Over Strea...
Apple Stares At Multi-Billion Dollar Hit Amid...
Target Margins And Inventory Issues Raise Ana...
Delta Charts Path To High Margins And Shareho...
Uber Launches 'XXL' Rides With Extra Trunk Sp...
Walmart Market Share Surges As Six-Figure Inc...
Super Micro Computer Shares Soar 32% As It Av...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ELI LILLY AND COMPANY (NYSE: LLY)

    Overview
    current price
    $753.41
    $753.41
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    753.41
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    4.15 M
    1 day
    0.00 - 0.00
    52 weeks
    561.65 - 972.53
    p/e
    81.45
    beta
    0.4335
    market cap
    715.22 B
    dividend yield
    0.69%
    Industry
    -
    LLY by TradingView
    News and Commentary
    Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip? Eli Lilly & Co. (LLY&nb...
    Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 weight-loss drugs like Ozempic.
    Market Update: Stocks Dip as More Big Tech Earnings Lay Ahead Stocks fell lower on Wednesday as investors weighed a large batch of quarterly earnings and looked ahead toward more mega-cap tech reports and a key labor market report later in...
    Market Update: Nasdaq Rises to Record Ahead of Big Tech Results The Nasdaq Composite climbed to a new record close on Tuesday ahead of big tech earnings later this week. The tech-heavy index rose nearly 0.8% to settle at 18,712.75 for the fir...
    FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears United States Senator Elizabeth Warren wrote a letter to the Federal Trade Commission's chair, Lina Khan, urging to investigate Novo Nordisk A/S
    Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite... Eli Lilly and Co (LLY&n...
    US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inf... On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)-CVS Health Inc's
    Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss Friday, the FDA approved Eli Lilly And Co's (
    Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound In a bid to meet escalating demand for its obesity drugs, pharmaceutical behemoth, Eli Lilly & Co.
    Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss C... At the European Association for the Study of Diabetes annual meeting, Novo Nordisk A/S
    StockTwits
    StockTwits
    Most Shared
    SolarEdge Q3 Results Miss Expectations; Analysts Warn Of Cash Flow Challenges And Need For Cost Cuts
    US Economy Grows Less Than Expected In Q3, Yet Private Employment Soars By 233,000 In October
    Netflix Crash Hits Jake Paul-Mike Tyson Fight: Can Streaming Platform Handle Christmas Day NFL Action?
    Most Popular
    Meta, Amazon, Microsoft Partner On Defense AI Initiative
    Ford CEO Jim Farley Says He Tries To Drive All Vehicles From Competition After Expressing Adoration For Xiaomi SU7: 'Try Me,' Says Tesla Cybertruck
    Palantir Overtakes Lockheed Martin In Market Cap, How Does The 'Messi Of AI' Stack Up Against The Traditional Defense Player
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Covid19
    Google
    Tesla
    mobile iOS Android
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2024 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?